Workiva (WK) 10-Q 3 May 22 2022 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2022	Apr. 28, 2022
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-36773
Entity Registrant Name	WORKIVA INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-2509828
Entity Address, Address Line One	2900 University Blvd
Entity Address, City or Town	Ames
Entity Address, State or Province	IA
Entity Address, Postal Zip Code	50010
City Area Code	888
Local Phone Number	275-3125
Title of 12(b) Security	Class A common stock, par value $.001
Trading Symbol	WK
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001445305
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Class A Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		48,186,532
Class B Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		3,890,583

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 303,076	$ 300,386
Marketable securities	220,457	230,060
Accounts receivable, net of allowance for doubtful accounts of $561 and $591 at March 31, 2022 and December 31, 2021, respectively	70,133	76,848
Deferred costs	31,816	31,152
Other receivables	3,359	3,538
Prepaid expenses and other	16,217	15,108
Total current assets	645,058	657,092
Property and equipment, net	28,091	28,821
Operating lease right-of-use assets	16,460	17,760
Deferred costs, non-current	30,879	33,091
Goodwill	34,556	34,556
Intangible assets, net	9,677	10,434
Other assets	5,162	5,005
Total assets	769,883	786,759
Current liabilities
Accounts payable	8,379	4,114
Accrued expenses and other current liabilities	71,589	84,126
Deferred revenue	259,387	258,023
Convertible senior notes, current	0	298,661
Finance lease obligations	1,257	1,575
Total current liabilities	340,612	646,499
Convertible senior notes, non-current	339,283	0
Deferred revenue, non-current	33,204	34,181
Other long-term liabilities	1,602	1,605
Operating lease liabilities, non-current	15,026	16,408
Finance lease obligations, non-current	14,963	15,087
Total liabilities	744,690	713,780
Stockholders’ equity
Preferred stock, $0.001 par value per share, 100,000,000 shares authorized, no shares issued and outstanding	0	0
Additional paid-in-capital	479,867	525,646
Accumulated deficit	(452,662)	(452,430)
Accumulated other comprehensive loss	(2,064)	(288)
Total stockholders’ equity	25,193	72,979
Total liabilities and stockholders’ equity	769,883	786,759
Class A Common Stock
Stockholders’ equity
Common stock	48	47
Class B Common Stock
Stockholders’ equity
Common stock	$ 4	$ 4

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Allowance for doubtful accounts	$ 561	$ 591
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, share authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	48,139,939	47,293,775
Common stock, shares outstanding	48,139,939	47,293,775
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, share authorized	500,000,000	500,000,000
Common stock, shares issued	3,890,583	4,150,583
Common stock, shares outstanding	3,890,583	4,150,583

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue
Total revenue	$ 129,674	$ 104,222
Cost of revenue
Total cost of revenue	30,873	23,676
Gross profit	98,801	80,546
Operating expenses
Research and development	35,884	26,634
Sales and marketing	56,100	41,035
General and administrative	23,994	17,021
Total operating expenses	115,978	84,690
Loss from operations	(17,177)	(4,144)
Interest income	280	360
Interest expense	(1,518)	(3,485)
Other expense, net	(165)	(384)
Loss before benefit for income taxes	(18,580)	(7,653)
Benefit for income taxes	(87)	(329)
Net loss	$ (18,493)	$ (7,324)
Net loss per common share:
Basic (in dollars per share)	$ (0.35)	$ (0.15)
Diluted (in dollars per share)	$ (0.35)	$ (0.15)
Weighted-average common shares outstanding - basic	52,596,228	50,244,120
Weighted-average common shares outstanding - diluted	52,596,228	50,244,120
Subscription and support
Revenue
Total revenue	$ 107,120	$ 84,936
Cost of revenue
Total cost of revenue	18,533	13,202
Professional services
Revenue
Total revenue	22,554	19,286
Cost of revenue
Total cost of revenue	$ 12,340	$ 10,474

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (18,493)	$ (7,324)
Other comprehensive loss, net of tax
Foreign currency translation adjustment, net of tax	84	156
Unrealized loss on available-for-sale securities, net of tax	(1,860)	(205)
Other comprehensive loss, net of tax	(1,776)	(49)
Comprehensive loss	$ (20,269)	$ (7,373)

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock (Class A and B)	Additional Paid-in-Capital	Additional Paid-in-CapitalCumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Accumulated DeficitCumulative Effect, Period of Adoption, Adjustment
Shares, Outstanding, Beginning at Dec. 31, 2020			48,789,000
Beginning of the period at Dec. 31, 2020	$ 64,277		$ 49	$ 478,698		$ 230	$ (414,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	11,623			11,623
Issuance of common stock upon exercise of stock options (in shares)			312,000
Issuance of common stock upon exercise of stock options	4,138		$ 1	4,137
Issuance of common stock under employee stock purchase plan (in shares)			93,000
Issuance of common stock under employee stock purchase plan	4,237			4,237
Issuance of restricted stock units (in shares)			803,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)			(70,000)
Tax withholding related to net share settlements of stock-based compensation awards	(7,146)			(7,146)
Net loss	(7,324)						(7,324)
Other comprehensive loss	(49)					(49)
Shares, Outstanding, Ending at Mar. 31, 2021			49,927,000
End of period at Mar. 31, 2021	69,756		$ 50	491,549		181	(422,024)
Shares, Outstanding, Beginning at Dec. 31, 2020			48,789,000
Beginning of the period at Dec. 31, 2020	64,277		$ 49	478,698		230	(414,700)
Shares, Outstanding, Ending at Dec. 31, 2021			51,444,000
End of period at Dec. 31, 2021	$ 72,979	$ (40,299)	$ 51	525,646	$ (58,560)	(288)	(452,430)	$ 18,261
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06 [Member]
End of period at Jan. 01, 2022					(58,600)			18,300
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06 [Member]
Shares, Outstanding, Beginning at Dec. 31, 2021			51,444,000
Beginning of the period at Dec. 31, 2021	$ 72,979	$ (40,299)	$ 51	525,646	$ (58,560)	(288)	(452,430)	$ 18,261
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 15,309			15,309
Issuance of common stock upon exercise of stock options (in shares)	62,237		62,000
Issuance of common stock upon exercise of stock options	$ 825		$ 1	824
Issuance of common stock under employee stock purchase plan (in shares)			53,000
Issuance of common stock under employee stock purchase plan	5,218			5,218
Issuance of restricted stock units (in shares)			545,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)			(73,000)
Tax withholding related to net share settlements of stock-based compensation awards	(8,570)			(8,570)
Net loss	(18,493)						(18,493)
Other comprehensive loss	(1,776)					(1,776)
Shares, Outstanding, Ending at Mar. 31, 2022			52,031,000
End of period at Mar. 31, 2022	$ 25,193		$ 52	$ 479,867		$ (2,064)	$ (452,662)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities
Net loss	$ (18,493)	$ (7,324)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	1,959	1,054
Stock-based compensation expense	15,309	11,623
Recovery of doubtful accounts	(29)	(118)
Amortization of premiums and discounts on marketable securities, net	660	625
Amortization of issuance costs and debt discount	324	2,266
Deferred income tax	(211)	(346)
Changes in assets and liabilities:
Accounts receivable	6,581	15,265
Deferred costs	1,444	(1,059)
Operating lease right-of-use asset	1,301	944
Other receivables	180	(161)
Prepaid expenses and other	(1,132)	(3,747)
Other assets	23	(573)
Accounts payable	4,364	1,908
Deferred revenue	606	179
Operating lease liability	(1,342)	(1,076)
Accrued expenses and other liabilities	(12,481)	(7,957)
Net cash (used in) provided by operating activities	(937)	11,503
Cash flows from investing activities
Purchase of property and equipment	(532)	(849)
Purchase of marketable securities	(34,148)	(43,655)
Sale of marketable securities	14,981	0
Maturities of marketable securities	26,250	40,586
Purchase of intangible assets	(40)	(71)
Net cash provided by (used in) investing activities	6,511	(3,989)
Cash flows from financing activities
Proceeds from option exercises	825	4,138
Taxes paid related to net share settlements of stock-based compensation awards	(8,570)	(7,146)
Proceeds from shares issued in connection with employee stock purchase plan	5,218	4,237
Principal payments on finance lease obligations	(442)	(417)
Net cash (used in) provided by financing activities	(2,969)	812
Effect of foreign exchange rates on cash	85	16
Net increase in cash and cash equivalents	2,690	8,342
Cash and cash equivalents at beginning of period	300,386	322,831
Cash and cash equivalents at end of period	303,076	331,173
Supplemental cash flow disclosure
Cash paid for interest	2,165	2,188
Cash paid for income taxes, net of refunds	190	20
Supplemental disclosure of noncash investing and financing activities
Purchases of property and equipment, accrued but not paid	$ 262	$ 0

Organization and Significant Ac

Organization and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Significant Accounting Policies	Organization and Significant Accounting Policies Organization Workiva Inc., a Delaware corporation, and its wholly-owned subsidiaries (the “Company” or “we” or “us”) simplifies complex work for thousands of organizations worldwide. We are a leading provider of cloud-based compliance and regulatory reporting solutions that are designed to solve business challenges at the intersection of data, process and people. Our operational headquarters are located in Ames, Iowa, with additional offices located in the United States, Europe, the Asia-Pacific region and Canada. Basis of Presentation and Principles of Consolidation The financial information presented in the accompanying unaudited condensed consolidated financial statements has been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, the financial statements do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The condensed consolidated balance sheet data as of December 31, 2021 was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting primarily of normal recurring accruals, necessary for a fair presentation of our financial position and results of operations. The operating results for the three months ended March 31, 2022 are not necessarily indicative of the results expected for the full year ending December 31, 2022. Seasonality has affected our revenue, expenses and cash flows from operations. Revenue from professional services has been higher in the first quarter as many of our customers file their Form 10-K in the first calendar quarter. Our sales and marketing expense also has some degree of seasonality. Sales and marketing expense has historically been higher in the third quarter due to our annual user conference in September. Our transition to a virtual event in September 2020 and September 2021 has mostly mitigated this trend, although we currently intend to sponsor a hybrid virtual and in-person event in 2022. In addition, the timing of the payments of cash bonuses to employees during the first and fourth calendar quarters may result in some seasonality in operating cash flow. The condensed consolidated financial information should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in this report and the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed with the SEC on February 22, 2022. The unaudited condensed consolidated financial statements include the accounts of Workiva Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and various other assumptions believed to be reasonable. These estimates include, but are not limited to, the allowance for doubtful accounts, the determination of the relative selling prices of our services, the measurement of material rights, health insurance claims incurred but not yet reported, valuation of available-for-sale marketable securities, useful lives of deferred contract costs, intangible assets and property and equipment, goodwill, income taxes, discount rates used in the valuation of right-of-use assets and lease liabilities, and certain assumptions used in the valuation of equity awards. While these estimates are based on our best knowledge of current events and actions that may affect us in the future, actual results may differ materially from these estimates. Recently Adopted Accounting Pronouncements In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which amends the accounting related to contract assets and liabilities acquired in business combinations. This ASU requires that entities recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers . This update is effective for fiscal years beginning after December 15, 2022 with early adoption permitted. We adopted this standard on January 1, 2022. The adoption of this standard did not have a material impact on our consolidated financial statements. In August 2020, the FASB issued ASU 2020-06 Accounting for Convertible Instruments and Contracts in an Entity's Own Equit y. Under ASU 2020-06, embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. The convertible debt instruments will now be accounted for as a single liability measured at amortized cost. This results in the interest expense recognized for convertible debt instruments to be closer to the coupon interest rate. The new guidance also requires the if-converted method to be applied for all convertible instruments when calculating earnings per share. The new standard is effective for interim and annual periods beginning after December 15, 2021 and can be adopted on either a modified retrospective or full retrospective basis. We adopted this standard on January 1, 2022 using the modified retrospective method under which financial results reported in prior periods were not adjusted. Adoption of the new standard resulted in a decrease to accumulated deficit of $18.3 million, a decrease to additional paid-in capital of $58.6 million, and an increase to convertible senior notes, non-current of $40.3 million on the consolidated balance sheet. See Note 5 to the condensed consolidated financial statements for more information. New Accounting Pronouncements Not Yet Adopted None.

Supplemental Consolidated Balan

Supplemental Consolidated Balance Sheet Information	3 Months Ended
	Mar. 31, 2022
Payables and Accruals [Abstract]
Supplemental Consolidated Balance Sheet Information	Supplemental Consolidated Balance Sheet Information Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): As of March 31, 2022 As of December 31, 2021 Accrued vacation $ 13,273 $ 11,221 Accrued commissions 4,875 11,122 Accrued bonuses 6,475 8,292 Accrued payroll 4,737 4,494 Estimated health insurance claims 1,885 1,814 Accrued interest 485 1,455 ESPP employee contributions 3,262 5,349 Customer deposits 23,675 26,517 Operating lease liabilities 5,929 6,008 Accrued other liabilities 6,993 7,854 $ 71,589 $ 84,126

Cash Equivalents and Marketable

Cash Equivalents and Marketable Securities	3 Months Ended
	Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Marketable Securities	Cash Equivalents and Marketable Securities At March 31, 2022, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 157,635 $ — $ — $ 157,635 Commercial paper 10,486 — — 10,486 U.S. treasury debt securities 55,324 6 (740) 54,590 Corporate debt securities 160,043 — (1,660) 158,383 Foreign government debt securities 1,000 — — 1,000 $ 384,488 $ 6 $ (2,400) $ 382,094 Included in cash and cash equivalents $ 161,637 $ — $ — $ 161,637 Included in marketable securities $ 222,851 $ 6 $ (2,400) $ 220,457 At December 31, 2021, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 259,754 $ — $ — $ 259,754 Commercial paper 10,479 — — 10,479 U.S. treasury debt securities 54,809 2 (206) 54,605 Corporate debt securities 161,792 3 (334) 161,461 Foreign government debt securities 5,014 1 — 5,015 $ 491,848 $ 6 $ (540) $ 491,314 Included in cash and cash equivalents $ 261,254 $ — $ — $ 261,254 Included in marketable securities $ 230,594 $ 6 $ (540) $ 230,060 The contractual maturities of the investments classified as marketable securities are as follows (in thousands): As of March 31, 2022 Due within one year $ 116,239 Due in one to two years 102,582 Due in three to five years 1,636 $ 220,457 The following table presents gross unrealized losses and fair values for those cash equivalents and marketable securities that were in an unrealized loss position as of March 31, 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in thousands): As of March 31, 2022 Less than 12 months 12 months or greater Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury debt securities $ 44,362 $ (710) $ 2,470 $ (30) Corporate debt securities 155,900 (1,635) 1,982 (25) Total $ 200,262 $ (2,345) $ 4,452 $ (55) We do not believe the unrealized losses represent credit losses based on our evaluation of available evidence as of March 31, 2022, which includes an assessment of whether it is more likely than not we will be required to sell the investment before recovery of the investment's amortized cost basis.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements We determine the fair values of our financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 - Inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 - Inputs are unobservable inputs based on our assumptions. Financial Assets Cash equivalents primarily consist of AAA-rated money market funds with overnight liquidity and no stated maturities. We classified cash equivalents as Level 1 due to the short-term nature of these instruments and measured the fair value based on quoted prices in active markets for identical assets. When available, our marketable securities are valued using quoted prices for identical instruments in active markets. If we are unable to value our marketable securities using quoted prices for identical instruments in active markets, we value our investments using broker reports that utilize quoted market prices for comparable instruments. We validate, on a sample basis, the derived prices provided by the brokers by comparing their assessment of the fair values of our investments against the fair values of the portfolio balances of another third-party professional pricing service. As of March 31, 2022, all of our marketable securities were valued using quoted prices for comparable instruments in active markets and are classified as Level 2. Based on our valuation of our money market funds and marketable securities, we concluded that they are classified in either Level 1 or Level 2, and we have no financial assets measured using Level 3 inputs on a recurring basis. The following table presents information about our assets that are measured at fair value on a recurring basis using the above input categories (in thousands): Fair Value Measurements as of March 31, 2022 Fair Value Measurements as of December 31, 2021 Description Total Level 1 Level 2 Total Level 1 Level 2 Money market funds $ 157,635 $ 157,635 $ — $ 259,754 $ 259,754 $ — Commercial paper 10,486 — 10,486 10,479 — 10,479 U.S. treasury debt securities 54,590 — 54,590 54,605 — 54,605 Corporate debt securities 158,383 — 158,383 161,461 — 161,461 Foreign government debt securities 1,000 — 1,000 5,015 — 5,015 $ 382,094 $ 157,635 $ 224,459 $ 491,314 $ 259,754 $ 231,560 Included in cash and cash equivalents $ 161,637 $ 261,254 Included in marketable securities $ 220,457 $ 230,060 Convertible Senior Notes As of March 31, 2022, the fair value of our convertible senior notes was $558.5 million. The fair value was determined based on the quoted price of the convertible senior notes in an over-the-counter market on the last trading day of the reporting period and has been classified as Level 2 in the fair value hierarchy. See Note 5 to the condensed consolidated financial statements for more information.

Convertible Senior Notes

Convertible Senior Notes	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Convertible Senior Notes	Convertible Senior NotesIn August 2019, we issued $345.0 million aggregate principal amount of 1.125% convertible senior notes due 2026 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, including the exercise in full by the initial purchasers of their option to purchase an additional $45.0 million principal amount (the “Notes”). The Notes were issued pursuant to an indenture and are senior, unsecured obligations of the Company. The Notes bear interest at a fixed rate of 1.125% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, commencing on February 15, 2020. Proceeds from the issuance of the Notes totaled $335.9 million, net of initial purchaser discounts and issuance costs. The initial conversion rate is 12.4756 shares of our common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $80.16 per share, subject to adjustment upon the occurrence of specified events. Holders of the Notes may convert all or a portion of their Notes prior to the close of business on May 15, 2026, in multiples of $1,000 principal amount, only under the following circumstances: • during any calendar quarter commencing after the calendar quarter ending on September 30, 2019 (and only during such calendar quarter), if the last reported sale price of our Class A common stock, par value $0.001 per share (which we refer to in this offering memorandum as our “Class A common stock”), for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; • during the five consecutive business day period immediately following any ten consecutive trading day period (the “measurement period”) in which the trading price (as defined below) per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our Class A common stock and the conversion rate on each such trading day; • if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or • upon the occurrence of certain specified corporate events as set forth in the indenture. On or after May 16, 2026, holders of the Notes may convert their Notes at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the Notes. Upon conversion, we will pay or deliver, as the case may be, cash, shares of our Class A common stock or a combination of cash and shares of our Class A common stock, at our election, in the manner and subject to the terms and conditions provided in the indenture. It is our current intent to settle conversions through a combination settlement of cash and shares of our Class A common stock with a specified dollar amount per $1,000 principal amount of Notes of $1,000. The Company may redeem for cash all or any portion of the Notes, at its option, on or after August 21, 2023, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus any accrued and unpaid interest to, but excluding, the redemption date. During the first quarter of 2022 none of the conversion conditions were met and the Notes are no longer convertible at the option of the holders. As a result, the Notes were classified as non-current liabilities on the condensed consolidated balance sheet as of March 31, 2022. As discussed in Note 1, we adopted ASU 2020‑06 on January 1, 2022 and the Notes are now accounted for as a single liability measured at amortized cost. Upon adoption, interest expense representing the amortization of the issuance costs as well as contractual interest expense is amortized to interest expense at an effective interest rate of 1.5% over the term of the notes. Prior to the adoption of ASU 2020-06, interest expense representing the amortization of the debt discount and issuance costs as well as contractual interest expense was amortized to interest expense at an effective interest rate of 4.3%. As of March 31, 2022 the if-converted value of the Notes exceeded the principal amount by $162.9 million. As of March 31, 2022, the remaining life of the Notes is approximately 4.4 years. The net carrying amount of the liability and equity components of the Notes was as follows (in thousands): March 31, 2022 December 31, 2021 Liability component: Principal $ 345,000 $ 345,000 Unamortized discount — (41,193) Unamortized issuance costs (5,717) (5,146) Net carrying amount $ 339,283 $ 298,661 Equity component, net of purchase discounts and issuance costs $ — $ 58,560 Interest expense related to the Notes is as follows (in thousands): Three months ended March 31, 2022 2021 Contractual interest expense $ 970 $ 971 Amortization of debt discount — 2,015 Amortization of issuance costs 324 251 Total interest expense $ 1,294 $ 3,237

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation From time to time we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We evaluate the development of legal matters on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Although the results of litigation and claims cannot be predicted with certainty, we currently believe that the final outcome of any currently pending legal proceedings to which we are a party will not have a material adverse effect on our business, operating results, financial condition or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation We grant stock-based incentive awards to attract, motivate and retain qualified employees, non-employee directors and consultants, and to align their financial interests with those of our stockholders. We utilize stock-based compensation in the form of restricted stock units, performance stock units, options to purchase Class A common stock and ESPP purchase rights. Prior to our corporate conversion in December 2014, awards were provided under the 2009 Unit Incentive Plan (“the 2009 Plan”). The 2009 Plan was amended to provide that no further awards will be issued thereunder, and our board of directors and stockholders adopted and approved our 2014 Equity Incentive Plan (“the 2014 Plan” and, together with the 2009 Plan, “the Plans”). Stock-Based Compensation Expense Stock-based compensation expense was recorded in the following cost and expense categories consistent with the respective employee or service provider’s related cash compensation (in thousands): Three months ended March 31, 2022 2021 Cost of revenue Subscription and support $ 790 $ 496 Professional services 452 367 Operating expenses Research and development 2,725 2,431 Sales and marketing 4,085 3,549 General and administrative 7,257 4,780 Total $ 15,309 $ 11,623 Stock Options The following table summarizes the option activity under the Plans for the three months ended March 31, 2022: Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (Years) Outstanding at December 31, 2021 1,755,180 $ 14.42 4.0 Granted — — Forfeited — — Exercised (62,237) 13.25 Outstanding at March 31, 2022 1,692,943 $ 14.47 3.8 Exercisable at March 31, 2022 1,692,943 $ 14.47 3.8 Restricted Stock Units The following table summarizes the restricted stock unit activity under the Plans for the three months ended March 31, 2022: Number of Shares Weighted- Average Grant Date Fair Value Unvested at December 31, 2021 1,891,699 $ 73.04 Granted 653,882 119.44 Forfeited (24,096) 83.18 Vested (1) (555,209) 56.82 Unvested at March 31, 2022 1,966,276 $ 92.96 (1) During the three months ended March 31, 2022, in accordance with our Nonqualified Deferred Compensation Plan, recipients of 12,368 shares had elected to defer settlement of the vested restricted stock units and 1,693 shares were released from deferral. During the first quarter of 2022, performance restricted stock units (“PSUs”) were granted for the first time to our executives under the 2014 Plan. The fair value of a PSU is determined using the closing price of our common stock on the grant date. Each PSU grant vests in annual tranches over a three-year service period. Total units earned for grants made in 2022 may vary between 0% and 200% of the units granted based on the attainment of company-specific performance targets during the related three-year period and upon continued service. Stock-based compensation expense for PSUs is recognized on a graded-vesting basis if it is probable that the performance conditions will be achieved. Adjustments to compensation expense are made each period based on changes in our estimate of the number of PSUs that are probable of vesting. PSUs will vest with continued service and upon achievement of the relevant performance targets. Employee Stock Purchase Plan During the three months ended March 31, 2022, 52,546 shares of common stock were purchased under the ESPP at a weighted-average price of $99.30 per share, resulting in cash proceeds of $5.2 million.

Revenue Recognition

Revenue Recognition	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue The following table presents our revenues disaggregated by industry (in thousands). Three months ended March 31, 2022 2021 Industrials $ 18,570 $ 13,877 Diversified financials 17,127 13,279 Information technology 14,637 10,663 Banks 12,985 11,610 Consumer discretionary 12,218 9,531 Healthcare 11,625 9,057 Insurance 7,777 6,584 Real estate 6,076 5,339 Utilities 5,960 4,828 Energy 5,746 5,284 Materials 5,674 4,846 Other 11,279 9,324 Total revenues $ 129,674 $ 104,222 Revenues by industry are derived from leading software providers. In the fourth quarter of 2021 we refined our policy surrounding customer industry categorization and accordingly the prior year amounts have been updated to reflect these refinements. The following table presents our revenues disaggregated by type of good or service (in thousands): Three months ended March 31, 2022 2021 Subscription and support $ 107,120 $ 84,936 XBRL professional services 17,693 14,486 Other services 4,861 4,800 Total revenues $ 129,674 $ 104,222 Deferred Revenue We recognized $101.1 million and $79.3 million of revenue during the three months ended March 31, 2022 and 2021, respectively, that was included in the deferred revenue balances at the beginning of the respective periods. Transaction Price Allocated to the Remaining Performance Obligations

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by giving effect to all potential shares of common stock, including convertible senior notes, outstanding stock options, stock related to unvested restricted stock units, and common stock issuable pursuant to the ESPP to the extent dilutive. Basic and diluted net loss per share was the same for each period presented, as the inclusion of all potential common shares outstanding would have been anti-dilutive. The net loss per share is allocated based on the participation rights of the Class A and Class B common shares as if the loss for the year has been distributed. As the liquidation and dividend rights are identical, the net loss is allocated on a proportionate basis. A reconciliation of the denominator used in the calculation of basic and diluted loss per share is as follows (in thousands, except share and per share data): Three months ended March 31, 2022 March 31, 2021 Class A Class B Class A Class B Numerator Net loss $ (17,079) $ (1,414) $ (6,161) $ (1,163) Denominator Weighted-average common shares outstanding - basic and diluted 48,575,645 4,020,583 42,264,288 7,979,832 Basic and diluted net loss per share $ (0.35) $ (0.35) $ (0.15) $ (0.15) The anti-dilutive securities excluded from the weighted-average shares used to calculate the diluted net loss per common share were as follows: As of March 31, 2022 March 31, 2021 Shares subject to outstanding common stock options 1,692,943 2,588,566 Shares subject to unvested restricted stock units 1,966,276 2,237,862 Shares issuable pursuant to the ESPP 64,043 59,359

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets The following table presents the components of net intangible assets (in thousands): As of March 31, 2022 As of December 31, 2021 Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Acquired technology 4 $ 7,920 $ (1,196) $ 6,724 $ 7,920 $ (701) $ 7,219 Acquired customer-related 8.7 360 (29) 331 360 (14) 346 Acquired trade names 2 1,478 (206) 1,272 1,478 (21) 1,457 Patents 10 2,780 (1,430) 1,350 2,740 (1,328) 1,412 Total 5.2 $ 12,538 $ (2,861) $ 9,677 $ 12,498 $ (2,064) $ 10,434 Amortization expense related to intangible assets was $0.8 million and $0.1 million for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022, expected remaining amortization expense of intangible assets by fiscal year is as follows (in thousands): Remainder of 2022 $ 2,274 2023 2,967 2024 2,206 2025 1,477 2026 167 2027 152 Thereafter 434 Total expected amortization expense $ 9,677

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsOn April 1, 2022, we acquired all of the issued and outstanding equity interests in Denmark-based ParsePort ApS (“ParsePort”), a leading solution provider for the European Single Electronic Format (“ESEF”) financial reporting mandate, which complements Workiva's cloud platform, for an aggregate cash purchase price of $100 million, subject to customary adjustments relating to the cash, working capital and indebtedness of ParsePort. We are currently in the process of valuing the assets acquired and liabilities assumed pursuant to the transaction. The accounting for this transaction is incomplete as of the date of our filing.

Organization and Significant _2

Organization and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	The financial information presented in the accompanying unaudited condensed consolidated financial statements has been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, the financial statements do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The condensed consolidated balance sheet data as of December 31, 2021 was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting primarily of normal recurring accruals, necessary for a fair presentation of our financial position and results of operations. The operating results for the three months ended March 31, 2022 are not necessarily indicative of the results expected for the full year ending December 31, 2022.
Principles of Consolidation	All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and various other assumptions believed to be reasonable. These estimates include, but are not limited to, the allowance for doubtful accounts, the determination of the relative selling prices of our services, the measurement of material rights, health insurance claims incurred but not yet reported, valuation of available-for-sale marketable securities, useful lives of deferred contract costs, intangible assets and property and equipment, goodwill, income taxes, discount rates used in the valuation of right-of-use assets and lease liabilities, and certain assumptions used in the valuation of equity awards. While these estimates are based on our best knowledge of current events and actions that may affect us in the future, actual results may differ materially from these estimates.
Recently Adopted Accounting Pronouncements and New Accounting Pronouncements Not Yet Adopted	In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which amends the accounting related to contract assets and liabilities acquired in business combinations. This ASU requires that entities recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers . This update is effective for fiscal years beginning after December 15, 2022 with early adoption permitted. We adopted this standard on January 1, 2022. The adoption of this standard did not have a material impact on our consolidated financial statements. In August 2020, the FASB issued ASU 2020-06 Accounting for Convertible Instruments and Contracts in an Entity's Own Equit y. Under ASU 2020-06, embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. The convertible debt instruments will now be accounted for as a single liability measured at amortized cost. This results in the interest expense recognized for convertible debt instruments to be closer to the coupon interest rate. The new guidance also requires the if-converted method to be applied for all convertible instruments when calculating earnings per share. The new standard is effective for interim and annual periods beginning after December 15, 2021 and can be adopted on either a modified retrospective or full retrospective basis.
Fair Value of Financial Instruments	Cash equivalents primarily consist of AAA-rated money market funds with overnight liquidity and no stated maturities. We classified cash equivalents as Level 1 due to the short-term nature of these instruments and measured the fair value based on quoted prices in active markets for identical assets. When available, our marketable securities are valued using quoted prices for identical instruments in active markets. If we are unable to value our marketable securities using quoted prices for identical instruments in active markets, we value our investments using broker reports that utilize quoted market prices for comparable instruments. We validate, on a sample basis, the derived prices provided by the brokers by comparing their assessment of the fair values of our investments against the fair values of the portfolio balances of another third-party professional pricing service.

Supplemental Consolidated Bal_2

Supplemental Consolidated Balance Sheet Information (Tables)	3 Months Ended
	Mar. 31, 2022
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): As of March 31, 2022 As of December 31, 2021 Accrued vacation $ 13,273 $ 11,221 Accrued commissions 4,875 11,122 Accrued bonuses 6,475 8,292 Accrued payroll 4,737 4,494 Estimated health insurance claims 1,885 1,814 Accrued interest 485 1,455 ESPP employee contributions 3,262 5,349 Customer deposits 23,675 26,517 Operating lease liabilities 5,929 6,008 Accrued other liabilities 6,993 7,854 $ 71,589 $ 84,126

Cash Equivalents and Marketab_2

Cash Equivalents and Marketable Securities (Tables)	3 Months Ended
	Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Marketable Securities	At March 31, 2022, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 157,635 $ — $ — $ 157,635 Commercial paper 10,486 — — 10,486 U.S. treasury debt securities 55,324 6 (740) 54,590 Corporate debt securities 160,043 — (1,660) 158,383 Foreign government debt securities 1,000 — — 1,000 $ 384,488 $ 6 $ (2,400) $ 382,094 Included in cash and cash equivalents $ 161,637 $ — $ — $ 161,637 Included in marketable securities $ 222,851 $ 6 $ (2,400) $ 220,457 At December 31, 2021, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 259,754 $ — $ — $ 259,754 Commercial paper 10,479 — — 10,479 U.S. treasury debt securities 54,809 2 (206) 54,605 Corporate debt securities 161,792 3 (334) 161,461 Foreign government debt securities 5,014 1 — 5,015 $ 491,848 $ 6 $ (540) $ 491,314 Included in cash and cash equivalents $ 261,254 $ — $ — $ 261,254 Included in marketable securities $ 230,594 $ 6 $ (540) $ 230,060
Schedule of Cash and Cash Equivalents	At March 31, 2022, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 157,635 $ — $ — $ 157,635 Commercial paper 10,486 — — 10,486 U.S. treasury debt securities 55,324 6 (740) 54,590 Corporate debt securities 160,043 — (1,660) 158,383 Foreign government debt securities 1,000 — — 1,000 $ 384,488 $ 6 $ (2,400) $ 382,094 Included in cash and cash equivalents $ 161,637 $ — $ — $ 161,637 Included in marketable securities $ 222,851 $ 6 $ (2,400) $ 220,457 At December 31, 2021, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 259,754 $ — $ — $ 259,754 Commercial paper 10,479 — — 10,479 U.S. treasury debt securities 54,809 2 (206) 54,605 Corporate debt securities 161,792 3 (334) 161,461 Foreign government debt securities 5,014 1 — 5,015 $ 491,848 $ 6 $ (540) $ 491,314 Included in cash and cash equivalents $ 261,254 $ — $ — $ 261,254 Included in marketable securities $ 230,594 $ 6 $ (540) $ 230,060
Summary of Investments Classified by Contractual Maturity Date	The contractual maturities of the investments classified as marketable securities are as follows (in thousands): As of March 31, 2022 Due within one year $ 116,239 Due in one to two years 102,582 Due in three to five years 1,636 $ 220,457
Schedule of Available-for-sale Securities, Continuous Unrealized Loss Position	The following table presents gross unrealized losses and fair values for those cash equivalents and marketable securities that were in an unrealized loss position as of March 31, 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in thousands): As of March 31, 2022 Less than 12 months 12 months or greater Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury debt securities $ 44,362 $ (710) $ 2,470 $ (30) Corporate debt securities 155,900 (1,635) 1,982 (25) Total $ 200,262 $ (2,345) $ 4,452 $ (55)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Assets Measured on Recurring Basis	The following table presents information about our assets that are measured at fair value on a recurring basis using the above input categories (in thousands): Fair Value Measurements as of March 31, 2022 Fair Value Measurements as of December 31, 2021 Description Total Level 1 Level 2 Total Level 1 Level 2 Money market funds $ 157,635 $ 157,635 $ — $ 259,754 $ 259,754 $ — Commercial paper 10,486 — 10,486 10,479 — 10,479 U.S. treasury debt securities 54,590 — 54,590 54,605 — 54,605 Corporate debt securities 158,383 — 158,383 161,461 — 161,461 Foreign government debt securities 1,000 — 1,000 5,015 — 5,015 $ 382,094 $ 157,635 $ 224,459 $ 491,314 $ 259,754 $ 231,560 Included in cash and cash equivalents $ 161,637 $ 261,254 Included in marketable securities $ 220,457 $ 230,060

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Summary of Convertible Debt	The net carrying amount of the liability and equity components of the Notes was as follows (in thousands): March 31, 2022 December 31, 2021 Liability component: Principal $ 345,000 $ 345,000 Unamortized discount — (41,193) Unamortized issuance costs (5,717) (5,146) Net carrying amount $ 339,283 $ 298,661 Equity component, net of purchase discounts and issuance costs $ — $ 58,560 Interest expense related to the Notes is as follows (in thousands): Three months ended March 31, 2022 2021 Contractual interest expense $ 970 $ 971 Amortization of debt discount — 2,015 Amortization of issuance costs 324 251 Total interest expense $ 1,294 $ 3,237

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Schedule of Stock-based Compensation Expense	Stock-based compensation expense was recorded in the following cost and expense categories consistent with the respective employee or service provider’s related cash compensation (in thousands): Three months ended March 31, 2022 2021 Cost of revenue Subscription and support $ 790 $ 496 Professional services 452 367 Operating expenses Research and development 2,725 2,431 Sales and marketing 4,085 3,549 General and administrative 7,257 4,780 Total $ 15,309 $ 11,623
Schedule of Stock-Option Activity	The following table summarizes the option activity under the Plans for the three months ended March 31, 2022: Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (Years) Outstanding at December 31, 2021 1,755,180 $ 14.42 4.0 Granted — — Forfeited — — Exercised (62,237) 13.25 Outstanding at March 31, 2022 1,692,943 $ 14.47 3.8 Exercisable at March 31, 2022 1,692,943 $ 14.47 3.8
Summary of Restricted Stock Units	The following table summarizes the restricted stock unit activity under the Plans for the three months ended March 31, 2022: Number of Shares Weighted- Average Grant Date Fair Value Unvested at December 31, 2021 1,891,699 $ 73.04 Granted 653,882 119.44 Forfeited (24,096) 83.18 Vested (1) (555,209) 56.82 Unvested at March 31, 2022 1,966,276 $ 92.96 (1) During the three months ended March 31, 2022, in accordance with our Nonqualified Deferred Compensation Plan, recipients of 12,368 shares had elected to defer settlement of the vested restricted stock units and 1,693 shares were released from deferral.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table presents our revenues disaggregated by industry (in thousands). Three months ended March 31, 2022 2021 Industrials $ 18,570 $ 13,877 Diversified financials 17,127 13,279 Information technology 14,637 10,663 Banks 12,985 11,610 Consumer discretionary 12,218 9,531 Healthcare 11,625 9,057 Insurance 7,777 6,584 Real estate 6,076 5,339 Utilities 5,960 4,828 Energy 5,746 5,284 Materials 5,674 4,846 Other 11,279 9,324 Total revenues $ 129,674 $ 104,222 The following table presents our revenues disaggregated by type of good or service (in thousands): Three months ended March 31, 2022 2021 Subscription and support $ 107,120 $ 84,936 XBRL professional services 17,693 14,486 Other services 4,861 4,800 Total revenues $ 129,674 $ 104,222

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	A reconciliation of the denominator used in the calculation of basic and diluted loss per share is as follows (in thousands, except share and per share data): Three months ended March 31, 2022 March 31, 2021 Class A Class B Class A Class B Numerator Net loss $ (17,079) $ (1,414) $ (6,161) $ (1,163) Denominator Weighted-average common shares outstanding - basic and diluted 48,575,645 4,020,583 42,264,288 7,979,832 Basic and diluted net loss per share $ (0.35) $ (0.35) $ (0.15) $ (0.15)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The anti-dilutive securities excluded from the weighted-average shares used to calculate the diluted net loss per common share were as follows: As of March 31, 2022 March 31, 2021 Shares subject to outstanding common stock options 1,692,943 2,588,566 Shares subject to unvested restricted stock units 1,966,276 2,237,862 Shares issuable pursuant to the ESPP 64,043 59,359

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Intangible Assets	The following table presents the components of net intangible assets (in thousands): As of March 31, 2022 As of December 31, 2021 Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Acquired technology 4 $ 7,920 $ (1,196) $ 6,724 $ 7,920 $ (701) $ 7,219 Acquired customer-related 8.7 360 (29) 331 360 (14) 346 Acquired trade names 2 1,478 (206) 1,272 1,478 (21) 1,457 Patents 10 2,780 (1,430) 1,350 2,740 (1,328) 1,412 Total 5.2 $ 12,538 $ (2,861) $ 9,677 $ 12,498 $ (2,064) $ 10,434
Schedule of Expected Amortization Expense of Intangible Assets	As of March 31, 2022, expected remaining amortization expense of intangible assets by fiscal year is as follows (in thousands): Remainder of 2022 $ 2,274 2023 2,967 2024 2,206 2025 1,477 2026 167 2027 152 Thereafter 434 Total expected amortization expense $ 9,677

Organization and Significant _3

Organization and Significant Accounting Policies - Accounting Pronouncements (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Dec. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06 [Member]	Accounting Standards Update 2020-06 [Member]
Stockholders' equity		$ 72,979	$ 25,193	$ 69,756	$ 64,277
Convertible senior notes, non-current		0	339,283
Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' equity		(452,430)	(452,662)	(422,024)	(414,700)
Additional Paid-in-Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' equity		525,646	$ 479,867	$ 491,549	$ 478,698
Cumulative Effect, Period of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' equity		(40,299)
Convertible senior notes, non-current	$ 40,300
Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' equity	18,300	18,261
Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-in-Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' equity	$ (58,600)	$ (58,560)

Supplemental Consolidated Bal_3

Supplemental Consolidated Balance Sheet Information - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Accrued Liabilities and Other Liabilities [Abstract]
Accrued vacation	$ 13,273	$ 11,221
Accrued commissions	4,875	11,122
Accrued bonuses	6,475	8,292
Accrued payroll	4,737	4,494
Estimated health insurance claims	1,885	1,814
Accrued interest	485	1,455
ESPP employee contributions	3,262	5,349
Customer deposits	23,675	26,517
Operating lease liabilities	5,929	6,008
Accrued other liabilities	6,993	7,854
Accrued expenses and other current liabilities	$ 71,589	$ 84,126

Cash Equivalents and Marketab_3

Cash Equivalents and Marketable Securities - Schedule of Marketable Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	$ 303,076	$ 300,386
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	222,851	230,594
Cash and cash equivalents and available-for-sale securities, amortized cost	384,488	491,848
Unrealized Gains	6	6
Unrealized Losses	(2,400)	(540)
Aggregate Fair Value	220,457	230,060
Cash and cash equivalents and available-for-sale securities	382,094	491,314
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	10,486	10,479
Unrealized Gains	0	0
Unrealized Losses	0	0
Aggregate Fair Value	10,486	10,479
U.S. treasury debt securities
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents and available-for-sale securities, amortized cost	55,324	54,809
Unrealized Gains	6	2
Unrealized Losses	(740)	(206)
Cash and cash equivalents and available-for-sale securities	54,590	54,605
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	160,043	161,792
Unrealized Gains	0	3
Unrealized Losses	(1,660)	(334)
Aggregate Fair Value	158,383	161,461
Foreign government debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,000	5,014
Unrealized Gains	0	1
Unrealized Losses	0	0
Aggregate Fair Value	1,000	5,015
Money market funds
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	157,635	259,754
Cash and cash equivalents, aggregate fair value	157,635	259,754
Cash Equivalents
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents	161,637	261,254
Cash and cash equivalents, aggregate fair value	$ 161,637	$ 261,254

Cash Equivalents and Marketab_4

Cash Equivalents and Marketable Securities - Schedule of Contractual Maturities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Due within one year	$ 116,239
Due in one to two years	102,582
Due in three to five years	1,636
Marketable securities	$ 220,457	$ 230,060

Cash Equivalents and Marketab_5

Cash Equivalents and Marketable Securities - Continuous Unrealized Loss Position (Details) $ in Thousands	Mar. 31, 2022USD ($)
Fair Value
Less than 12 months	$ 200,262
12 months or greater	4,452
Unrealized Loss
Less than 12 months	(2,345)
12 months or greater	(55)
U.S. treasury debt securities
Fair Value
Less than 12 months	44,362
12 months or greater	2,470
Unrealized Loss
Less than 12 months	(710)
12 months or greater	(30)
Corporate debt securities
Fair Value
Less than 12 months	155,900
12 months or greater	1,982
Unrealized Loss
Less than 12 months	(1,635)
12 months or greater	$ (25)

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 220,457	$ 230,060
Cash and cash equivalents and available-for-sale securities	382,094	491,314
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	10,486	10,479
U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents and available-for-sale securities	54,590	54,605
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	158,383	161,461
Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	1,000	5,015
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents - money market funds	157,635	259,754
Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents - money market funds	161,637	261,254
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of convertible debt	558,500
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	220,457	230,060
Total assets measured at fair value	382,094	491,314
Recurring | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	10,486	10,479
Recurring | U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents and available-for-sale securities	54,590	54,605
Recurring | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	158,383	161,461
Recurring | Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	1,000	5,015
Recurring | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents - money market funds	157,635	259,754
Recurring | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents - money market funds	161,637	261,254
Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	157,635	259,754
Recurring | Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring | Level 1 | U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents and available-for-sale securities	0	0
Recurring | Level 1 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring | Level 1 | Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring | Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents - money market funds	157,635	259,754
Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	224,459	231,560
Recurring | Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	10,486	10,479
Recurring | Level 2 | U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents and available-for-sale securities	54,590	54,605
Recurring | Level 2 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	158,383	161,461
Recurring | Level 2 | Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	1,000	5,015
Recurring | Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents - money market funds	$ 0	$ 0

Convertible Senior Notes (Detai

Convertible Senior Notes (Details)	1 Months Ended	3 Months Ended
	Aug. 31, 2019USD ($)day$ / shares	Mar. 31, 2022USD ($)$ / shares	Jan. 01, 2022	Dec. 31, 2021$ / shares
Class A Common Stock
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.001	$ 0.001		$ 0.001
Convertible debt | 1.125% Convertible Senior Notes Due 2026
Debt Instrument [Line Items]
Face amount of debt issued | $	$ 345,000,000
Stated interest percentage	1.125%
Proceeds from the issuance of convertible senior notes, net of issuance costs | $	$ 335,900,000
Conversion ratio	0.0124756
Conversion price (in dollars per share) | $ / shares	$ 80.16
Threshold number of trading days (day)	20
Threshold number of consecutive trading days (day)	30
Threshold percentage of stock price trigger	130.00%
Redemption price, percentage	100.00%
Effective interest percentage	4.30%		1.50%
If-converted value in excess of principal | $		$ 162,900,000
Remaining life of debt instrument		4 years 4 months 24 days
Convertible debt | 1.125% Convertible Senior Notes Due 2026 | Debt Conversion Terms, One
Debt Instrument [Line Items]
Threshold number of trading days (day)	20
Threshold number of consecutive trading days (day)	30
Threshold percentage of stock price trigger	130.00%
Convertible debt | 1.125% Convertible Senior Notes Due 2026 | Debt Conversion Terms, Two
Debt Instrument [Line Items]
Threshold number of trading days (day)	5
Threshold number of consecutive trading days (day)	10
Threshold percentage of stock trading price	98.00%
Convertible debt | Over-allotment option
Debt Instrument [Line Items]
Face amount of debt issued | $	$ 45,000,000

Convertible Senior Notes - Summ

Convertible Senior Notes - Summary of Convertible Debt (Details) - 1.125% Convertible Senior Notes Due 2026 - Convertible debt - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Principal	$ 345,000	$ 345,000
Unamortized discount	0	(41,193)
Unamortized issuance costs	(5,717)	(5,146)
Net carrying amount	$ 339,283	298,661
Equity component, net of purchase discounts and issuance costs		$ 58,560

Convertible Senior Notes - Su_2

Convertible Senior Notes - Summary of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Debt Disclosure [Abstract]
Contractual interest expense	$ 970	$ 971
Amortization of debt discount	0	2,015
Amortization of issuance costs	324	251
Total interest expense	$ 1,294	$ 3,237

Stock-Based Compensation - Expe

Stock-Based Compensation - Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 15,309	$ 11,623
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	2,725	2,431
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	4,085	3,549
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	7,257	4,780
Subscription and support | Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	790	496
Professional services | Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 452	$ 367

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Options (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Options (in shares):
Outstanding beginning of the period (in shares)	1,755,180
Granted (in shares)	0
Forfeited (in shares)	0
Exercised (in shares)	(62,237)
Outstanding end of the period (in shares)	1,692,943	1,755,180
Exercisable (in shares)	1,692,943
Weighted-Average Exercise Price (in dollars per share):
Outstanding beginning of the period (in dollars per share)	$ 14.42
Granted (in dollars per share)	0
Forfeited (in dollars per share)	0
Exercised (in dollars per share)	13.25
Outstanding end of the period (in dollars per share)	14.47	$ 14.42
Exercisable (in dollars per share)	$ 14.47
Outstanding, weighted-average remaining contractual term (years)	3 years 9 months 18 days	4 years
Exercisable, weighted-average remaining contractual term (years)	3 years 9 months 18 days

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Units (Details)	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Restricted stock units
Number of Shares (in shares)
Unvested at beginning of period (in shares)	1,891,699
Granted (in shares)	653,882
Forfeited (in shares)	(24,096)
Vested (in shares)	(555,209)
Unvested at end of period (in shares)	1,966,276
Weighted- Average Grant Date Fair Value (in dollars per share)
Unvested at beginning of period (in dollars per share) | $ / shares	$ 73.04
Granted (in dollars per share) | $ / shares	119.44
Forfeited (in dollars per share) | $ / shares	83.18
Vested (in dollars per share) | $ / shares	56.82
Unvested at end of period (in dollars per share) | $ / shares	$ 92.96
Number of vested shares recipient elected to defer settlement (in shares)	12,368
Number of vested shares recipients elected to defer settlement, released during period (in shares)	1,693
Performance Shares
Weighted- Average Grant Date Fair Value (in dollars per share)
Award vesting period (years)	3 years
Performance Shares | Minimum
Weighted- Average Grant Date Fair Value (in dollars per share)
Units earned, percentage of units granted	0.00%
Performance Shares | Maximum
Weighted- Average Grant Date Fair Value (in dollars per share)
Units earned, percentage of units granted	200.00%

Stock-Based Compensation - Empl

Stock-Based Compensation - Employee Stock Purchase Plan (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from shares issued in connection with employee stock purchase plan	$ 5,218	$ 4,237
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	$ 1,200
Unrecognized compensation expense, period for recognition (years)	3 months 18 days
Class A Common Stock | Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued during period (in shares)	52,546
Shares issued during period, weighted average price per share (in dollars per share)	$ 99.3
Proceeds from shares issued in connection with employee stock purchase plan	$ 5,200

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 129,674	$ 104,222
Subscription and support
Disaggregation of Revenue [Line Items]
Total revenue	107,120	84,936
XBRL professional services
Disaggregation of Revenue [Line Items]
Total revenue	17,693	14,486
Other services
Disaggregation of Revenue [Line Items]
Total revenue	4,861	4,800
Industrials
Disaggregation of Revenue [Line Items]
Total revenue	18,570	13,877
Diversified financials
Disaggregation of Revenue [Line Items]
Total revenue	17,127	13,279
Information technology
Disaggregation of Revenue [Line Items]
Total revenue	14,637	10,663
Banks
Disaggregation of Revenue [Line Items]
Total revenue	12,985	11,610
Consumer discretionary
Disaggregation of Revenue [Line Items]
Total revenue	12,218	9,531
Healthcare
Disaggregation of Revenue [Line Items]
Total revenue	11,625	9,057
Insurance
Disaggregation of Revenue [Line Items]
Total revenue	7,777	6,584
Real estate
Disaggregation of Revenue [Line Items]
Total revenue	6,076	5,339
Utilities
Disaggregation of Revenue [Line Items]
Total revenue	5,960	4,828
Energy
Disaggregation of Revenue [Line Items]
Total revenue	5,746	5,284
Materials
Disaggregation of Revenue [Line Items]
Total revenue	5,674	4,846
Other
Disaggregation of Revenue [Line Items]
Total revenue	$ 11,279	$ 9,324

Revenue Recognition - Deferred

Revenue Recognition - Deferred Revenue and Transaction Price Allocated to the Remaining Performance Obligations (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized	$ 101.1	$ 79.3
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized	603.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized	$ 351.1
Expected period of recognition	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected period of recognition	24 months

Net Loss Per Share - Earnings P

Net Loss Per Share - Earnings Per Share Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Denominator
Weighted-average common shares outstanding - basic	52,596,228	50,244,120
Weighted-average common shares outstanding - diluted	52,596,228	50,244,120
Basic net loss per share (in dollars per share)	$ (0.35)	$ (0.15)
Diluted net loss per share (in dollars per share)	$ (0.35)	$ (0.15)
Class A Common Stock
Numerator
Net loss, basic	$ (17,079)	$ (6,161)
Net loss, diluted	$ (17,079)	$ (6,161)
Denominator
Weighted-average common shares outstanding - basic	48,575,645	42,264,288
Weighted-average common shares outstanding - diluted	48,575,645	42,264,288
Basic net loss per share (in dollars per share)	$ (0.35)	$ (0.15)
Diluted net loss per share (in dollars per share)	$ (0.35)	$ (0.15)
Class B Common Stock
Numerator
Net loss, basic	$ (1,414)	$ (1,163)
Net loss, diluted	$ (1,414)	$ (1,163)
Denominator
Weighted-average common shares outstanding - basic	4,020,583	7,979,832
Weighted-average common shares outstanding - diluted	4,020,583	7,979,832
Basic net loss per share (in dollars per share)	$ (0.35)	$ (0.15)
Diluted net loss per share (in dollars per share)	$ (0.35)	$ (0.15)

Net Loss Per Share - Antidiluti

Net Loss Per Share - Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Class A Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	4,300,000	4,300,000
Shares subject to outstanding common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,692,943	2,588,566
Shares subject to unvested restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,966,276	2,237,862
Shares issuable pursuant to the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	64,043	59,359

Intangible Assets - Intangible

Intangible Assets - Intangible Asset Components (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	5 years 2 months 12 days
Gross Carrying Amount	$ 12,538	$ 12,498
Accumulated Amortization	(2,861)	(2,064)
Net Carrying Amount	$ 9,677	10,434
Acquired technology
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	4 years
Gross Carrying Amount	$ 7,920	7,920
Accumulated Amortization	(1,196)	(701)
Net Carrying Amount	$ 6,724	7,219
Acquired customer-related
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	8 years 8 months 12 days
Gross Carrying Amount	$ 360	360
Accumulated Amortization	(29)	(14)
Net Carrying Amount	$ 331	346
Acquired trade names
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	2 years
Gross Carrying Amount	$ 1,478	1,478
Accumulated Amortization	(206)	(21)
Net Carrying Amount	$ 1,272	1,457
Patents
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	10 years
Gross Carrying Amount	$ 2,780	2,740
Accumulated Amortization	(1,430)	(1,328)
Net Carrying Amount	$ 1,350	$ 1,412

Intangible Assets (Details)

Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense related to intangible assets	$ 0.8	$ 0.1

Intangible Assets - Amortizatio

Intangible Assets - Amortization of Intangible Assets by Fiscal Year (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2022	$ 2,274
2023	2,967
2024	2,206
2025	1,477
2026	167
2027	152
Thereafter	434
Net Carrying Amount	$ 9,677	$ 10,434

Subsequent Events (Details)

Subsequent Events (Details) $ in Millions	Apr. 01, 2022USD ($)
Subsequent Event | ParsePort ApS
Subsequent Event [Line Items]
Payments to acquire businesses	$ 100